FRIDAY, April 18, 2025 — Midafternoon dosing with beclomethasone dipropionate is associated with better clinical outcomes in mild-to-moderate atopic asthma, according to a study published online April 15 in Thorax.
Ran Wang, Ph.D., from the NIHR…Original Article
Midafternoon Dosing Improves Lung Function in Atopic Asthma
FRIDAY, April 18, 2025 — Midafternoon dosing with beclomethasone dipropionate is associated with better clinical outcomes in mild-to-moderate atopic asthma, according to a study published online April 15 in Thorax.
Ran Wang, Ph.D., from the NIHR…
